Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension

Autor: Stearman, Robert S, Cornelius, Amber R, Lu, Xiao, Conklin, David S, Del Rosario, Mark J, Lowe, Anita M, Elos, Mihret T, Fettig, Lynsey M, Wong, Randall E, Hara, Naoko, Cogan, Joy D, Phillips, John A, Taylor, Matthew R, Graham, Brian B, Tuder, Rubin M, Loyd, James E, Geraci, Mark W

Publikováno v: American journal of respiratory and critical care medicine, vol 189, iss 9

RationalePulmonary arterial hypertension (PAH) is a progressive disease characterized by elevated pulmonary artery pressure, vascular remodeling, and ultimately right ventricular heart failure. PAH can have a genetic component (heritable PAH), most o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::4454bcd673fa3b1ae6a93bfe3648edf5
https://escholarship.org/uc/item/2c40v26w

Functional prostacyclin synthase promoter polymorphisms. Impact in pulmonary arterial hypertension.

Autor: Stearman RS; 1 Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Denver, School of Medicine, Aurora, Colorado., Cornelius AR, Lu X, Conklin DS, Del Rosario MJ, Lowe AM, Elos MT, Fettig LM, Wong RE, Hara N, Cogan JD, Phillips JA 3rd, Taylor MR, Graham BB, Tuder RM, Loyd JE, Geraci MW

Publikováno v: American journal of respiratory and critical care medicine [Am J Respir Crit Care Med] 2014 May 01; Vol. 189 (9), pp. 1110-20.